Showing 1–25 of 61 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Seminars in Oncology ISSN: 0093-7754 / 1532-8708Top Tier | 🇺🇸United States | Q1 | CAS Tier 4 | 6.8 | 1.536Q1 | 125 | 33 | 3.3% | W.B. Saunders Ltd | Profile |
| 2 | Clinical Lymphoma Myeloma & Leukemia ISSN: 2152-2650 / 2152-2669 | 🇺🇸United States | Q1 | CAS Tier 3 | 4.1 | 0.615Q2 | — | 230 | 3.7% | Cancer Media Group | Profile |
| 3 | Current Hematologic Malignancy Reports ISSN: 1558-8211 / 1558-822XTop Tier | 🇺🇸United States | Q2 | CAS Tier 3 | 4 | 1.191Q1 | 28 | 55 | 3.7% | Springer US | Profile |
| 4 | Oncology Reviews ISSN: 1970-5557 / 1970-5565Top Tier | 🌐Italy | Q2 | CAS Tier 3 | 4 | 1.096Q2 | — | 14 | 0% | PAGEPress Publications | Profile |
| 5 | Breast Cancer-Targets and Therapy ISSN: 1179-1314 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.6 | 0.992Q2 | — | 54 | 3% | Dove Medical Press | Profile |
| 6 | Current Oncology ISSN: 1198-0052 / 1718-7729 | 🌐Canada | Q2 | CAS Tier 3 | 3.6 | 1.132Q2 | 42 | 437 | 7.1% | Multimed Inc. | Profile |
| 7 | Journal of Breast Cancer ISSN: 1738-6756 | 🌐South Korea | Q2 | CAS Tier 4 | 3.6 | 0.89Q2 | 29 | 52 | 4.5% | Korean Breast Cancer Society | Profile |
| 8 | World Journal of Clinical Oncology ISSN: 2218-4333 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.6 | — | — | 89 | 0% | Baishideng Publishing Group | Profile |
| 9 | Cancer Treatment and Research Communications ISSN: 2468-2942 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.5 | 0.995Q2 | — | 320 | N/A | Elsevier | Profile |
| 10 | Cancer Prevention Research ISSN: 1940-6207 / 1940-6215 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.4 | 1.129Q1 | 80 | 102 | 3.4% | American Association for Cancer Research Inc. | Profile |
| 11 | Oncology and Therapy ISSN: 2366-1070 / 2366-1089 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.4 | 1.159Q2 | — | 42 | 0% | Adis, Springer Healthcare | Profile |
| 12 | Lung Cancer: Targets and Therapy ISSN: 1179-2728 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.3 | — | — | 8 | N/A | Dove Medical Press | Profile |
| 13 | Blood and Lymphatic Cancer-Targets and Therapy ISSN: 1179-9889 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.2 | — | — | 6 | 0% | Dove Medical Press | Profile |
| 14 | Infectious Agents and Cancer ISSN: 1750-9378 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.2 | 0.92Q2 | 30 | 66 | 3.2% | BioMed Central | Profile |
| 15 | American Journal of Cancer Research ISSN: 2156-6976 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.1 | — | 20 | 381 | 2.8% | E-CENTURY PUBLISHING CORP | Profile |
| 16 | Cancer Control ISSN: 1073-2748 / 1526-2359 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.1 | 0.907Q1 | 66 | 133 | 4% | H. Lee Moffitt Cancer Center and Research Institute | Profile |
| 17 | Future Oncology ISSN: 1479-6694 / 1744-8301 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.1 | 1.229Q1 | 60 | 390 | 3.3% | Future Medicine Ltd. | Profile |
| 18 | Journal of Immunotherapy and Precision Oncology ISSN: 2666-2345 / 2590-017X | 🌐International | Q3 | CAS Tier 4 | 3.1 | 1.37Q1 | — | 6 | N/A | Innovative Healthcare Institute | Profile |
| 19 | Cancer Epidemiology ISSN: 1877-7821 / 1877-783X | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3 | 1.036Q2 | 68 | 144 | 4.2% | Elsevier BV | Profile |
| 20 | Expert Review of Anticancer Therapy ISSN: 1473-7140 / 1744-8328 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3 | 0.84Q2 | 59 | 99 | 0% | Taylor and Francis Ltd. | Profile |
| 21 | International Journal of Clinical Oncology ISSN: 1341-9625 / 1437-7772 | 🇯🇵Japan | Q3 | CAS Tier 3 | 3 | 0.945Q1 | 53 | 239 | 0% | Springer Singapore | Profile |
| 22 | Journal of Geriatric Oncology ISSN: 1879-4068 / 1879-4076 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 2.9 | 0.943Q2 | 27 | 187 | 16.7% | Elsevier Ltd | Profile |
| 23 | Hereditary Cancer in Clinical Practice ISSN: 1731-2302 / 1897-4287 | 🌐Poland | Q3 | CAS Tier 3 | 2.8 | 1.049Q2 | 21 | 45 | 5% | BioMed Central | Profile |
| 24 | World Journal of Surgical Oncology ISSN: 1477-7819 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.8 | 0.761Q1 | 48 | 341 | 4% | BioMed Central | Profile |
| 25 | Acta Oncologica ISSN: 0284-186X / 1651-226X | 🌐Norway | Q3 | CAS Tier 3 | 2.7 | 0.952Q1 | 88 | 186 | 7.4% | Informa Healthcare | Profile |